Energy metabolism and the intestinal barrier: implications for understanding and managing intestinal diseases
- PMID: 39959156
- PMCID: PMC11826063
- DOI: 10.3389/fmicb.2025.1515364
Energy metabolism and the intestinal barrier: implications for understanding and managing intestinal diseases
Abstract
The interplay between energy metabolism and the gut barrier is crucial for maintaining intestinal physiological homeostasis. Energy metabolism and the intestinal barrier perform distinct yet complementary roles that uphold intestinal ecological equilibrium. Disruptions in energy metabolism can compromise the integrity of the intestinal barrier; for example, inactivation of the AMPK pathway may lead to reduced expression of proteins associated with tight junctions. Conversely, impairment of the intestinal barrier can result in metabolic dysregulation, such as alterations in the gut microbiota that impede the production of short-chain fatty acids (SCFAs), which are essential substrates for energy metabolism. This disruption can affect energy production and modify the gut's hypoxic environment. Imbalances in these systems have been associated with the onset of various intestinal diseases. Research indicates that dietary interventions, such as a low FODMAP diet, can enhance the colonization of probiotics and improve the fermentation metabolism of SCFAs. Pharmacological strategies to elevate SCFA levels can activate the AMPK pathway and rectify abnormalities in energy metabolism. This review provides a comprehensive summary of recent advancements in elucidating the interactions between energy metabolism and the intestinal barrier.
Keywords: SCFAs; cross-talk; energy metabolism; intestinal barrier; intestinal diseases.
Copyright © 2025 Chen, Shen, Zeng, Sun, Luo, Wan, Zhang, Chen, Hou, Wang, Zheng and Li.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


References
-
- Abdelmalak M. F. L., Abdelrahim D. S., George Michael T. M. A., Abdel-Maksoud O. M., Labib J. M. W. (2023). Vitamin D and lactoferrin attenuate stress-induced colitis in Wistar rats via enhancing AMPK expression with inhibiting mTOR-STAT3 signaling and modulating autophagy. Cell Biochem. Funct. 41 211–222. 10.1002/cbf.3774 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources